BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Tariff (miscellaneous tariff bills) TAR
GENERAL DISCUSSIONS REGARDING SECTION 232 INVESTIGATION ON BIOPHARMACEUTICALS
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN EDWARD GREISSING | — |
Health Issues HCR
GENERAL DISCUSSIONS REGARDING GENETIC TESTING AND NEWBORN SCREENING GENERAL DISCUSSIONS REGARDING ORPHAN DRUGS GENERAL DISCUSSIONS RELATED TO THE PRIORITY REVIEW VOUCHER PROGRAM EXTENSION GENERAL DISCUSSIONS RELATED TO TARIFFS ON PHARMACEUTICALS GENERAL DISCUSSIONS RELATED TO METABOLIC DISORDER PUBLIC HEALTH CAMPAIGN GENERAL DISCUSSIONS RELATED TO RARE DISEASE DRUG DEVELOPMENT
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN EDWARD GREISSING | — |
| KATHRYN LOWELL | — |
Medicare/Medicaid MMM
GENERAL DISCUSSIONS RELATED TO MOST-FAVORED-NATION (MFN) FOREIGN REFERENCE PRICING GENERAL DISCUSSIONS REGARDING MEDICAID PRIOR AUTHORIZATION
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN EDWARD GREISSING | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.